One-Shot gene therapy aims to halt blinding eye disease
Disease control
Recruiting now
This early-stage study is testing a new, one-time gene therapy injection for people with geographic atrophy, an advanced form of age-related macular degeneration that causes permanent vision loss. The goal is to see if the treatment is safe and if it can slow or stop the growth o…
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 05:57 UTC